Jason Raleigh Nunn insider trades
Open-market stock purchases and sales by Jason Raleigh Nunn, Director at Addex Therapeutics Ltd, from SEC Form 4 filings since Jan 14, 2010.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +57%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd | Sold (not open market) | — |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd | Bought (not open market) | — |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd | Sold (not open market) | — |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd | Bought (not open market) | — |
| Jun 15, 2026 | ZBIO Zenas BioPharma, Inc | Bought (not open market) | — |
Companies traded
- ADXN Addex Therapeutics Ltd: other filings, last Sep 2, 2026
- ZBIO Zenas BioPharma, Inc: 2 buys, last Jun 15, 2026
- RGLS Regulus Therapeutics Inc: other filings, last Jun 25, 2025
- TRVN Trevena Inc: other filings, last Jun 13, 2024
- DERM Dermira, Inc: other filings, last Feb 20, 2020
- TRIV TriVascular Technologies, Inc: other filings, last May 22, 2015
- HPTX Hyperion Therapeutics Inc: other filings, last May 7, 2015
- TSPT Transcept Pharmaceuticals Inc: other filings, last Oct 30, 2014